Electrophysiological evidence for an inverse benzodiazepine receptor agonist in panic disorder

Journal of Psychiatric Research

Volumn 33, Issue 1, 1999, Pages 1-5

  Roschke J ^a   Kogel P ^a   Wagner, P ^a   Grozinger M ^a   Hevers, W ^a   Schlegel, S ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

frequency range; Panic disorder; Quantitative EEG

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; BENZODIAZEPINE RECEPTOR STIMULATING AGENT;

ADULT; AGORAPHOBIA; ARTICLE; BETA RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; ELECTROENCEPHALOGRAM; ELECTROPHYSIOLOGY; FEMALE; FREQUENCY ANALYSIS; HUMAN; HYPERVENTILATION; MALE; NORMAL HUMAN; PANIC; PRIORITY JOURNAL;

ADULT; AGORAPHOBIA; ANALYSIS OF VARIANCE; ELECTRIC IMPEDANCE; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; FEMALE; HUMANS; HYPERVENTILATION; MALE; PANIC DISORDER; RECEPTORS, GABA-A;

EID: 0344096550     PISSN: 00223956     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3956(98)00050-8     Document Type: Article

References (21)

1. Ballenger JC. Efficacy of benzodiazepines in panic disorder and agoraphobia. Journal of Psychiatric Research 1990;24 (Suppl 2):15-25.
2. Ballenger JC, Burrows GD, DuPont Jr. RL, Lesser IM, Noyes Jr. R, Pecknold JC, Rifkin A, Swinson RP. Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment. Archives of General Psychiatry 1988;45:413-422.
3. Breimer LT, Hennis PJ, Burm AG, Danhof M, Bovill JG, Spierdijk J, Vletter AA. Pharmacokinetics and EEG effects of flumazenil in volunteers. Clinical Pharmacokinetics 1991;20:491-496.
4. Dorow R, Horowski R, Paschelke G, Amin M, Braestrup C. Severe anxiety induced by FR7142, a β-carboline ligand for benzodiazepine receptors. The Lancet 1988;2:98-99.
5. Gasser T, Bacher P, Mocks J. Transformation towards normal distribution of broad band spectral parameters of the EEG. Electroencephalography and Clinical Neurophysiology 1982;53:119-124.
6. Gentil V, Tarares S, Gorenstein C, Bello C, Mathias L, Gromich G, Singer J. Acute reversal of flumitrazepam effects by Ro 15-1788 and Ro 15-3505: inverse agoniom, tolerance and rebound. Psychopharmacology 1990;100:54-59.
7. Greene SA, Moore MP, Keegan RD, Gallagher LV. Quantitative electroencephalography for measurement of central nervous system responses to diazepam and the benzodiazepine antagonist, flumazenil, in isoflurane-anaesthetized dogs. Journal Vet Pharmacology Therapeutics 1992;15:259-266.
8. Knott VJ, Bakish D, Lusk S, Barkely J, Perugini M. Quantitative EEG Correlates of panic disorder. Psychiatry Research Neuroimaging 1996;68:31-39.
9. Lepola U, Nousiainen U, Puranen M, Riekkinen P, Rimon R. EEG and CT findings in patients with panic disorder. Biological Psychiatry 1990;28:721-727.
10. Mandema JW, Kuck MT, Danhof M. Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship. British Journal of Pharmacology 1992;105:164-170.
11. Mandema JW, Tukker E, Danhof M. In vivo characterization of the pharmacodynamic interaction of a benzodiazepine agonist and antagonist: midazolam and flumazenil. Journal of Pharmacology and Experimental Therapeutics 1992;260:36-44.
12. Moy SS, Knapp DJ, Criswell HE, Brase GR. Flumazenil blockade of anxious ethanol withdrawal in rats. Psychopharmacology 1997;131:354-360.
13. Nutt DJ, Glue P, Lawson C, Wilson S. Flumazenil provocation of panic attacks: evidence for altered benzodiazepine receptor sensitivity in panic disorder. Archives of General Psychiatry 1990;47:917-925.
14. Pelissolo A. The benzodiazepine receptor: the enigma of the endogenous ligand. Encephale 1995;21:133-140.
15. Pollack MH, Rosenbaum JF, Tesar GE, Herman JB, Sachs GS. Clonazepam in the treatment of panic disorder and agoraphobia. Psychopharmacology Bulletin 1987;23:141-144.
16. Rickels K, Schweizer EE. Benzodiazepines for treatment of panic attacks: a new look. Psychopharmacology Bulletin 1986;22:93-99.
17. Schlegel S, Steinert H, Bockisch A, Hahn K, Schloesser R, Benkert O. Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT: a preliminary report. European Archives of Psychiatry and Clinical Neuroscience 1994;244:49-51.
18. Schulte am Esch J, Kochs E. Midazolam and flumazenil in neuroanaesthesia. Acta Anaesthesiology Scandinavica 1990;92 (Suppl):96-102.
19. Sheehan DV. Benzodiazepines in panic disorder and agoraphobia. Journal of Affective Disorders 1987;13:169-181.
20. Tang AH, Franklin SR, Himes CS, Ho PM. Behavioral effects of U-78875, a quinoxalinone anxiolytic with potent benzodiazepine antagonist activity. Journal of Pharmacology and Experimental Therapeutics 1991;259:248-254.
21. Woods SW, Charney DS, Silver JM, Krystal JH, Heninger GR. Behavioral, biochemical, and cardiovascular responses to the benzodiazepine receptor antagonist flumazenil in panic disorder. Psychiatry Research 1991;36:115-127.